Fight With Care
80% of cancer patients suffer from harsh skin side effects of their treatments*, that can lead to a temporary or permanent discontinuation of their therapy.
Discover the new Oncology Atlas
Navigate the complexities of cancer treatment-induced skin side effects clarity.
Our new oncology atlas offers comprehensive visual support, featuring detailed descriptions alongside real-life images to enhance your patient care.
Our new oncology atlas offers comprehensive visual support, featuring detailed descriptions alongside real-life images to enhance your patient care.
Resources for your Practice
The COCOON Global Randomized Controlled Trial
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
La Roche-posay is proud to presents its updated cancer support report 2026
Dive into this document to discover a comprehensive and updated overview of the diverse actions and initiatives undertaken as part of La Roche-Posay's ongoing commitment to oncology.
.jpg?rev=b52c449f2fa44b3e9e5e59a0a36161a8&cx=0.41&cy=0.44&cw=1024&ch=687&hash=B67600E17CB30517C93495F764EF8965)
The healing power of touch
What if a caring touch could make a difference?
*Charles C, et al. Impact of cutaneous toxicity associated with targeted therapies on quality of life. Results of a longitudinal exploratory study. Bulletin du Cancer. March 2013;100(3):213-22.
Leading the way in supportive care in oncology
Join Prof Kiarash Khosrotehrani, Director, Frazer Institute, and Kerry Patford, Chief Nurse, McGrath Foundation, at the World Cancer Leaders’ Summit as they deepdive into supportiove care in oncology